The role of next-generation sequencing (NGS) to integrate identified genomic alterations (GA) into cancer treatment decisions in gastrointestinal (GI) tumors.

e22115 Background: GI cancers account for about 20% of all cancers diagnosed in the US. Therapeutic options in relapsed/refractory disease are limited and the outcomes are poor. Advanced therapeuti...